Detalles de la búsqueda
1.
Design of Bio-Optical Transceiver for In Vivo Biomedical Sensor Applications.
Sensors (Basel)
; 24(8)2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38676201
2.
Sharding-Based Proof-of-Stake Blockchain Protocols: Key Components & Probabilistic Security Analysis.
Sensors (Basel)
; 23(5)2023 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905022
3.
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Cancer
; 128(6): 1194-1205, 2022 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34882781
4.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
; 130(5): 592-603, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34597472
5.
Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer: Results From an Administrative Dataset.
Alzheimer Dis Assoc Disord
; 36(4): 307-311, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36183417
6.
Age-related deep white matter changes in myelin and water content: A T2 relaxometry study.
J Magn Reson Imaging
; 50(5): 1393-1404, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30859698
7.
Design and Evaluation of a Receiver for Wired Nano-Communication Networks.
IEEE Trans Nanobioscience
; 22(2): 223-236, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35696477
8.
Simulation and Performance Evaluation of a Bio-Inspired Nanogenerator for Medical Applications.
IEEE Trans Biomed Eng
; 70(9): 2616-2623, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37030752
9.
Critical evaluation and comparison of nutritional clinical practice guidelines for cancer patients.
Clin Nutr
; 42(5): 670-686, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36944289
10.
Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
PLoS One
; 18(11): e0294382, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37943834
11.
Development and validation of a prognostic nomogram for overall and disease-specific survival in patients with sarcomatoid urothelial carcinoma.
Urol Oncol
; 41(6): 296.e17-296.e28, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36931981
12.
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
PLoS One
; 18(2): e0277708, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36763597
13.
Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
PLoS One
; 18(11): e0294384, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37943779
14.
Role of Underlying Liver Pathology in the Development of Immune-Related Hepatitis: A Case-Control Study.
Target Oncol
; 18(4): 601-610, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358780
15.
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 21(2): 286-294, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36481176
16.
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer
; 21(2): 265-272, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36710146
17.
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
Clin Genitourin Cancer
; 21(5): 584-593, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414620
18.
Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances.
World J Clin Oncol
; 13(6): 448-472, 2022 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35949435
19.
Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies.
Life (Basel)
; 12(6)2022 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35743911
20.
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(6): 558-567, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36155169